These results indicated that NSC-94258 may ameliorate the reduced insulin sensitivity and hyperandrogenemia of PCOS by targeting and regulating AKR1B1, CYP19A1, HSD17B1. We assumed that the correlation between DMGs and potential drugs stems from insulin resistance. The gene discussed is AKR1B1; the disease is polycystic ovary syndrome.